Intuitive Surgical: FY26 Q1 earnings call, Apr 21, 2026
No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Apr 21, 2026 earnings call (FY26 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
18 matches for “Ion”; 5 quoted, at least 25 words apart.
…by 17% total procedure growth and broad-based adoption across da Vinci and Ion, as customers continue to advance minimally invasive care. In Q1, da Vinci…
…systems, 34 SP systems, and 34 Xi-R systems. We also placed 52 Ion systems in the quarter. As da Vinci 5 moves into broader clinical…
Moving to Ion, we're pleased with the results and progress this quarter. Ion's North Star is to help physicians improve lung cancer patient survival. Clinical…
…total procedures and their related growth rates include both da Vinci and Ion procedures. Before detailing our quarterly results, I would like to briefly address…
…17%, reflecting 16% growth in da Vinci procedures and 39% growth in Ion procedures. Quarter one revenue increased 23% to $2.77 billion, with recurring revenue…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-04-21:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-04-21:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP